Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niaogan Fang is a traditional Chinese medicine (TCM) formulation investigated for the treatment of acute simple urinary tract infection (UTI), specifically in patients diagnosed with Xiajiao damp-heat syndrome according to TCM criteria. It is being studied in randomized controlled clinical trials, often as an adjunct or comparator to standard antibiotic therapy such as levofloxacin. The precise herbal composition, mechanism of action, and pharmacological targets are not specified in available sources. Its use reflects TCM principles aimed at clearing heat and dampness from the lower burner (Xiajiao), which corresponds to the genitourinary system in Western medicine[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Niaogan Fang.